Trial Profile
Effects of colesevelam HCl on hepatic insulin sensitivity, gluconeogenesis, glucose absorption and lipid synthesis in subjects with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Colesevelam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Dec 2011 Results published in Diabetologia.
- 02 Oct 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes
- 09 Jun 2009 Results have been published as an abstract in the proceedings of the 69th Annual Scientific Sessions of the American Diabetes Association.